Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance.
Visentin A, Pravato S, Castellani F, Campagnolo M, Angotzi F, Cavarretta CA, Cellini A, Ruocco V, Salvalaggio A, Tedeschi A, Trentin L, Briani C. Visentin A, et al. Among authors: cavarretta ca. Cancers (Basel). 2022 Mar 18;14(6):1562. doi: 10.3390/cancers14061562. Cancers (Basel). 2022. PMID: 35326711 Free PMC article. Review.
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study.
Visentin A, Mauro FR, Scarfò L, Gentile M, Farina L, Reda G, Ferrarini I, Proietti G, Derenzini E, Cibien F, Vitale C, Sanna A, Pietrasanta D, Marchetti M, Murru R, Rigolin GM, Sportoletti P, Trimarco V, Cavarretta CA, Angotzi F, Cellini A, Ruocco V, Zatta I, Laurenti L, Molica S, Coscia M, Ghia P, Foà R, Cuneo A, Trentin L. Visentin A, et al. Among authors: cavarretta ca. Am J Hematol. 2023 Sep;98(9):E237-E240. doi: 10.1002/ajh.27009. Epub 2023 Jun 29. Am J Hematol. 2023. PMID: 37382471 No abstract available.
Anaemia during venetoclax ramp-up phase: Do not forget unusual causes.
Cavarretta CA, Visentin A, Pravato S, Piva E, Piazza F, Basso D, Trentin L. Cavarretta CA, et al. Int J Lab Hematol. 2022 Oct;44(5):e211-e214. doi: 10.1111/ijlh.13875. Epub 2022 May 11. Int J Lab Hematol. 2022. PMID: 35538897 No abstract available.
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course.
Angotzi F, Cellini A, Ruocco V, Cavarretta CA, Zatta I, Serafin A, Pravato S, Pagnin E, Bonaldi L, Frezzato F, Facco M, Piazza F, Trentin L, Visentin A. Angotzi F, et al. Among authors: cavarretta ca. Cancers (Basel). 2024 Mar 8;16(6):1095. doi: 10.3390/cancers16061095. Cancers (Basel). 2024. PMID: 38539430 Free PMC article.